ST Elevated Myocardial Infarction Clinical Trial
Official title:
Smartphone Twelve Lead Electrocardiogram Utility In ST Elevation Myocardial Infarction
The primary objective is to determine if the Smartphone electrocardiogram (ECG) is an acceptable replacement for a standard ECG in the identification of ST elevation myocardial infarction (STEMI).
Toward this objective, this study involves the following:
- Obtain simultaneous recordings of a standard 12-lead ECG and the iPhone "12-lead
equivalent" ECG on patients presenting with chest pain in which the STEMI protocol was
activated.
- Obtain simultaneous recordings of a standard 12-lead ECG and the iPhone "12-lead
equivalent" ECG on patients presenting to the Emergency Department for evaluation of
chest pain, not necessarily presenting with STEMI.
- Reading of ECGs (standard 12-lead and iPhone) by three independent cardiologists, who
are blinded to the initial clinical ECG readings, the type of ECG equipment used, and
the patient's clinical information.
- Assess the operational feasibility of using the Smartphone to obtain "12-lead
equivalent" ECG recordings in patients suspected to have STEMI, and
- Determine the possibility of pooling the data obtained from this study with data from
other institutions conducting identical studies, and developing a future IRB-approved
protocol and statistical analysis plan to compare the sensitivity, specificity, positive
predictive value and the negative predictive power of the iPhone ECG, using a paired
standard 12-lead ECG as the gold standard.
There will be no therapeutic interventions. A single research-related procedure will be
required, i.e. an iPhone ECG. Effort will be made to ensure that the performance of this
procedure will not delay any treatment and/or diagnostic procedures that are part of usual or
specialized care that the patient requires. Effort will be made to enroll 1 STEMI patient for
every 2 non-STEMI patients.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04183140 -
Comparison of Radial and Ulnar Artery Intervention in Patients With ST Elevated Myocardial Infarction
|
N/A | |
Recruiting |
NCT04002739 -
PRedictOrs, PHEnotypes and Timing of Obstructive Sleep Apnea in Acute Coronary Syndrome
|
N/A | |
Recruiting |
NCT05211401 -
Rituximab in Patients With ST-elevation Myocardial Infarction
|
Phase 2 | |
Recruiting |
NCT05491200 -
Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI Patients
|
Phase 4 | |
Completed |
NCT01663194 -
Neutrophil/Lymphocyte (N/L) Ratio and Long Term Follow-up in ST-elevation Myocardial Infarction
|
N/A | |
Recruiting |
NCT05752617 -
European Registry On Plaque ModifiCAtion in the STEMI Population (ROCA-STEMI)
|
||
Completed |
NCT04887571 -
the PrEsentation, Rationale and Impact of reperFUSION for Acute Coronary Syndromes in Cape Town and the Garden Route Health District - the PERFUSION Registry
|